US Stock MarketDetailed Quotes

NVO Novo-Nordisk A/S

Watchlist

90.950
+0.360+0.40%

Close Feb 25 16:00 ET

91.040
+0.090+0.10%

Pre 05:28 ET

403.88BMarket Cap28.50P/E (TTM)

Novo-Nordisk A/S Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Novo-Nordisk A/S Q4 2024 Earnings Date

Currency：USDFeb 5, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	11.18B	11.95B	+767.80M
Beat Est.	+14.69%	+22.56%	+6.86%
EPS	0.85	0.88	+0.03
Beat Est.	+17.33%	+21.65%	+3.68%

Analyst Rating

Buy

Feb 25, 2025

Novo-Nordisk A/S Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: DKK

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 84.818B	--
--	2025/Q1	-- / 81.833B	--
Feb 5, 2025	2024/Q4	85.683B / 80.179B	--
Nov 6, 2024	2024/Q3	71.311B / 71.869B	--
Aug 7, 2024	2024/Q2	68.060B / 68.563B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 84.818B--

--2025/Q1-- / 81.833B--

Feb 5, 20252024/Q485.683B / 80.179B

Novo Nordisk Q4 2023 earnings conference call

Jan 31 06:00

Replay

Nov 6, 20242024/Q371.311B / 71.869B--

Aug 7, 20242024/Q268.060B / 68.563B--

Unlock Free Earnings Estimates

Open Account

Novo-Nordisk A/S Earnings Reports

6-K: Financial Report for the Period 1 January 2024 to 31 December 2024

Feb 5 07:20 ET

20-F: FY2024 Annual Report

Feb 5 07:09 ET

6-K: Financial Report for the Period 1 January 2024 to 30 September 2024

Nov 6, 2024 06:37 ET

6-K: Financial Report for the Period 1 January 2024 to 30 June 2024

Aug 7, 2024 06:56 ET

Trending Stocks

Symbol Mini Chart % Chg

Unlock the Full List

Analysis

Analyst Rating

Updated: Feb 25, 2025

Buy

Buy
71.43%
Hold
14.29%
Sell
14.29%

Price Target

No Data

Investment Theme

Weight Loss Drugs

Intraday+1.58%